在肝硬化患者中治疗凝血障碍的指导方针
I Aiza-Haddad1, L E Cisneros-Garza2, O Morales-Gutiérrez3
1Clínica de Enfermedades Hepáticas, Hospital Ángeles Lomas, Mexico City, Mexico.
Revista de gastroenterologia de Mexico (English)
|April 10, 2024
概括
肝硬化的凝血重新平衡,从出血风险转移到包括血栓事件. 这些指导方针涵盖肝病患者的血液静止,出血和高凝血能力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 肝硬化的凝血管理已经发展,挑战了普遍出血倾向的传统观点.
- 在肝硬化中,促凝和抗凝因子的再平衡揭示了血栓事件的风险.
- 了解这些转变对于管理肝病患者至关重要.
研究的目的:
- 提供关于肝硬化患者凝血管理的全面指导方针.
- 详细介绍病理生理机制,出血和血栓并发症以及诊断/治疗策略.
- 更新关于肝脏疾病中的高凝血性和抗凝血性的知识.
主要方法:
- 对肝硬化中血静的病理生理机制的审查.
- 对门高血压,机械出血因素和肝脏合成变化的分析.
- 在急性肝衰竭中评估网膜内endothelial系统的功能.
主要成果:
- 肝硬化涉及复杂的静血再平衡,而不仅仅是出血的透析.
- 血栓性并发症越来越多地与出血风险一起被认可.
- 介绍了关于诊断和管理肝硬化的凝血障碍的新见解.
结论:
- 肝硬化的凝血管理需要一个细微的方法,解决出血和血栓形成.
- 这些指导方针为药理治疗,输血产品和抗凝药提供了最新的建议.
- 包括急性肝衰竭,脱补偿和肝移植的具体考虑.
关键词:
流血 出血 流血 出血慢性肝病是一种慢性肝病.肝硬化是肝硬化的一种疾病.肝硬化是肝硬化的一种疾病.他患有慢性肝病.发生出血 发生出血 发生出血血液静止 静止 血液静止血液静止 血液静止 血液静止血栓形成的原因是血栓形成.血栓形成 血栓形成 血栓形成更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.0K
相关概念视频
Disorders of Hemostasis
881
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
881
Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Coagulation
6.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.4K
Extrinsic and Intrinsic Pathways of Hemostasis
7.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.4K
Introduction to Hemostasis
7.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.5K
